In this study, we hypothesized that CD44-ve cells exist in tumors in addition to conventional CSCs and that these cells, which emerge when the chemotherapeutic agents’ concentration and overall tumor stress increase, are involved in tumor growth and resistance after chemotherapeutic agents. Here, CD44 is linked to neoplasm.